Neurochemical coding of the enteric nervous system in chagasic patients with megacolon

Digestive Diseases and Sciences

Volumn 52, Issue 10, 2007, Pages 2877-2883

  Da Silveira, A B M ^a   D'Avila Reis, D ^a   De Oliveira, E C ^b   Neto, S G ^b   Luquetti, A O ^b   Poole, D ^c   Correa Oliveira, R ^d   Furness, J B ^c  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Chagas' disease; Chagasic megacolon; Enteric nervous system; Neurochemical markers; Neuropeptides

Indexed keywords

BIOLOGICAL MARKER; CALRETININ; CCHAT ENZYME; CHOLINE ACETYLTRANSFERASE; NEUROPEPTIDE; NITRIC OXIDE SYNTHASE; NUCLEAR FACTOR Y; PROTEIN ANTIBODY; SUBSTANCE P; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; AGED; ARTICLE; CELL POPULATION; CHAGAS DISEASE; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; FROZEN SECTION; GENETIC CODE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE INNERVATION; MALE; MEGACOLON; MOTONEURON; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TRYPANOSOMA CRUZI;

AGED; CHAGAS DISEASE; COLON; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEGACOLON; MICROSCOPY, CONFOCAL; MIDDLE AGED; NEUROPEPTIDES; SEVERITY OF ILLNESS INDEX; SUBMUCOUS PLEXUS;

EID: 34548488449     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9680-5     Document Type: Article

References (34)

1. Nowicki MJ, Chinchilla C, Corado L, Matsuoka L, Selby R, Steurer F, Mone T, Mendez R, Aswad S (2006) Prevalence of antibodies to trypanosoma cruzi among solid organ donors in southern California: a population at risk. Transplantation 81:477-479
2. Chapadeiro E (1999) Clinical evolution and morbi-mortality in chagas disease. Mem Inst Oswaldo Cruz 94 (Suppl 1):309-310
3. Prata A (2001) Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 1:92-100
4. Koberle F (1968) Chagas' disease and Chagas' syndromes: the pathology of American trypanosomiasis. Adv Parasitol 6:63-116
5. Adad SJ, Cancado CG, Etchebehere RM, Teixeira VP, Gomes UA, Chapadeiro E, Lopes ER (2001) Neuron count reevaluation in the myenteric plexus of chagasic megacolon after morphometric neuron analysis. Virchows Arch 438:254-258
6. Dias JC, Silveira AC, Schofield CJ (2002) The impact of Chagas disease control in Latin America: a review. Mem Inst Oswaldo Cruz 97:603-612
7. Gattuso JM, Kamm MA (1993) Review article: The management of constipation in adults. Aliment Pharmacol Ther 7:487-500
8. Gama AH, Raia A, Netto AC (1971) Motility of the sigmoid colon and rectum: contribution to the physiopathology of megacolon in Chagas' disease. Dis Colon Rectum 14:291-304
9. Okumura M, Netto AC (1963) [Etiopathogenesis of Chagas' megacolon. Experimental contribution]. Rev Hosp Clin Fac Med Sao Paulo 18:351-360 (in Portuguese)
10. Grider JR (1989) Identification of neurotransmitters regulating intestinal peristaltic reflex in humans. Gastroenterology 97:1414-1419
11. Furness JB, Young HM, Pompolo S, Bornstein JC, Kunze WAA, McConalogue K (1995) Plurichemical transmission and chemical coding of neurons in the digestive tract. Gastroenterology 108:554-563
12. Matini P, Faussone Pellegrini MS, Cortesini C, Mayer B (1995) Vasoactive intestinal polypeptide and nitric oxide synthase distribution in the enteric plexuses of the human colon: an histochemical study and quantitative analysis. Histochemistry 103:415-423
13. Wattchow DA, Furness JB, Costa M (1988) Distribution and coexistence of peptides in nerve fibers of the external muscle of the human gastrointestinal tract. Gastroenterology 95:32-41
14. Porter AJ, Wattchow DA, Brookes SJ, Schemann M, Costa M (1996) Choline acetyltransferase immunoreactivity in the human small and large intestine. Gastroenterology 111:401-408
15. Koch TR, Carney JA, Go VL (1987) Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases. Dig Dis Sci 32:369-376
16. Bernstein CN, Robert ME, Eysselein VE (1993) Rectal substance P concentrations are increased in ulcerative colitis but not in Crohn's disease. Am J Gastroenterol 88:908-913
17. Mantyh CR, Vigna SR, Maggio JE, Mantyh PW, Bollinger RR, Pappas TN (1994) Substance P binding sites on intestinal lymphoid aggregates and blood vessels in inflammatory bowel disease correspond to authentic nk-1 receptors. Neurosci Lett 178:255-259
18. Holzer P (1998) Implications of tachykinins and calcitonin gene-related peptide in inflammatory bowel disease. Digestion 59:269-283
19. Kishimoto S, Machino H, Kobayashi H, Haruma K, Kajiyama G, Miyoshi A, Fujii K (1994) Inhibitory action of cck-op on rat proximal colon. Ann NY Acad Sci 713:407-409
20. Kusafuka T, Puri P (1997) Altered mRNA expression of the neuronal nitric oxide synthase gene in Hirschsprung's disease. J Pediatr Surg 32:1054-1058
21. Guo R, Nada O, Suita S, Taguchi T, Masumoto K (1997) The distribution and co-localization of nitric oxide synthase and vasoactive intestinal polypeptide in nerves of the colons with Hirschsprung's disease. Virchows Arch 430:53-61
22. Vanderwinden JM, De Laet MH, Schiffmann SN, Mailleux P, Lowenstein CJ, Snyder SH, Vanderhaeghen JJ (1993) Nitric oxide synthase distribution in the enteric nervous system of Hirschsprung's disease. Gastroenterology 105:969-973
23. Bealer JF, Natuzzi ES, Flake AW, Adzick NS, Harrison MR (1994) Effect of nitric oxide on the colonic smooth muscle of patients with Hirschsprung's disease. J Pediatr Surg 29:1025-1029
24. Cuffari C, Rubin SZ, Krantis A (1993) Routine use of the nitric oxide stain in the differential diagnosis of Hirschsprung's disease. J Pediatr Surg 28:1202-1204
25. O'Kelly T, Brading A, Mortensen N (1993) Nerve mediated relaxation of the human internal anal sphincter: the role of nitric oxide. Gut 34:689-693
26. Burleigh DE, D'Mello A, Parks AG (1979) Responses of isolated human internal anal sphincter to drugs and electrical field stimulation. Gastroenterology 77:484-490
27. Gustafsson BI, Delbro DS (1993) Tonic inhibition of small intestinal motility by nitric oxide. J Auton Nerv Syst 44:179-187
28. Moore BG, Singaram C, Eckhoff DE, Gaumnitz EA, Starling JR (1996) Immunohistochemical evaluations of ultrashort-segment Hirschsprung's disease. report of three cases. Dis Colon Rectum 39:817-822
29. Sanders KM, Ward SM, Thornbury KD, Dalziel HH, Westfall DP, Carl A (1992) Nitric oxide as a non-adrenergic, non-cholinergic neurotransmitter in the gastrointestinal tract. Jpn J Pharmacol 58(Suppl 2):220P-225P
30. O'Kelly TJ, Davies JR, Brading AF, Mortensen NJ (1994) Distribution of nitric oxide synthase containing neurons in the rectal myenteric plexus and anal canal. Morphologic evidence that nitric oxide mediates the rectoanal inhibitory reflex. Dis Colon Rectum 37:350-357
31. Li CG, Rand MJ (1989) Evidence for a role of nitric oxide in the neurotransmitter system mediating relaxation of the rat anococcygeus muscle. Clin Exp Pharmacol Physiol 16:933-938
32. Loder PB, Kamm MA, Nicholls RJ, Phillips RK (1994) 'Reversible chemical sphincterotomy' by local application of glyceryl trinitrate. Br J Surg 81:1386-1389
33. Lund JN, Scholefield JH (1997) A randomised, prospective, double-blind, placebo-controlled trial of glyceryl trinitrate ointment in treatment of anal fissure. Lancet 349:11-14
34. Schouten WR, Briel JW, Boerma MO, Auwerda JJ, Wilms EB, Graatsma BH (1996) Pathophysiological aspects and clinical outcome of intra-anal application of isosorbide dinitrate in patients with chronic anal fissure. Gut 39:465-469